Assessing the quality of pharmacy journals accessible to community pharmacists.

evidence-based practice pharmaceutical care pharmacist consultation pharmacists pharmacy pharmacy practice

Journal

Journal of clinical pharmacy and therapeutics
ISSN: 1365-2710
Titre abrégé: J Clin Pharm Ther
Pays: England
ID NLM: 8704308

Informations de publication

Date de publication:
Oct 2021
Historique:
revised: 19 04 2021
received: 16 02 2021
accepted: 11 05 2021
pubmed: 3 6 2021
medline: 12 1 2022
entrez: 2 6 2021
Statut: ppublish

Résumé

Low-quality journals are problematic for the scientific community. They may not provide thorough editorial and peer review services, and may spread low-quality information. Community pharmacists are limited in research time and resources, and are particularly at risk to access low-quality information published in some journals. This may negatively impact their professional decision-making and patient care. This study aimed to assess pharmaceutical journals readily accessible to community pharmacists and classify those journals using multiple quality criteria. A Google search was performed using defined English and German keywords. The following quality indicators were utilized: (i) whether the journal was listed on a blacklist or whitelist, (ii) whether the journal or its publisher was a member of a publishing organization, (iii) evaluation of details on the journal's website, (iv) indexation of the journal, and (v) use of journal metrics. Three hundred and eight journals were analysed; 105 (34%) were classified as "high-quality" and 203 (66%) were classified as "other". Forty-six journals (15%) were listed on a blacklist and 152 journals (49%) were listed on a whitelist. Most journals were headquartered in India (39%), followed by the USA (24%) and Europe (20%). Journals classified as "high-quality" charged higher open access article processing charges (APCs) (median APC: USD $960; interquartile range (IQR): USD $27 to USD $3,000) than journals classified as "other" (USD $100, IQR: USD $13 to USD $547), p = 0.003. Similarly, journals indexed in established databases (MEDICUS, MEDLINE, PUBMED, Embase, Science Citation Index Expanded, or SCOPUS) charged higher APCs (median APC: USD $600, IQR: USD $4 to USD $2,500) than journals indexed in non-standard databases (median APC: USD $100, IQR: USD $41 to USD $581), p = 0.001. The results indicate that community pharmacists are at risk of accessing journals of questionable quality. Patient care may be negatively impacted by community pharmacists basing their professional decisions on evidence gained from some sources of lower quality. Community pharmacists and other pharmacists and researchers can use the tools and quality indicators provided in this study to preliminarily determine the quality and reliability of a journal to assist their professional decision-making and patient care.

Identifiants

pubmed: 34075599
doi: 10.1111/jcpt.13444
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1343-1348

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Shen C, Björk B-C. ‘Predatory’ open access: a longitudinal study of article volumes and market characteristics. BMC Med. 2015;13:230.
Elsevier [cited 2019 Jun 29]. Available from: www.elsevier.com
Clarivate Analytics [cited 2019 Jun 29]. Available from: www.clarivate.com
Xia J, Smith M. Alternative journal impact factors in open access publishing. Learn Publ. 2018;31(4):403-411.
Beall's list of predatory journals and publishers [cited 2020 Oct 08]. Available from: https://beallslist.net/
Stop Predatory Journals [cited 2020 May 20]. Available from: www.predatoryjournals.com/journals
Cabells [cited 2019 Jun 25]. Available from: www.cabells.com
Directory of Open Access Journals (DOAJ) [cited 2019 Jun 30]. Available from: www.doaj.org
Strinzel M, Severin A, Milzow K, Egger M. Blacklists and whitelists to tackle predatory publishing: a cross-sectional comparison and thematic analysis. MBio. 2019;10(3):e00411-e419.
International Committee of Medical Journal Editors (ICMJE) [cited 2020 May 20]. Available from: www.icmje.org
Committee on Publication Ethics (COPE) [cited 2019 Jun 26]. Available from: www.publicationethics.org
Open Access Scholarly Publishers Association (OASPA) [cited 2019 Jun 26]. Available from: www.oaspa.org
World Association of Medical Editors (WAME) [cited 2020 May 20]. Available from: www.wame.org
NLM Catalog [cited 2020 May 20]. Available from: https://www.ncbi.nlm.nih.gov/nlmcatalog
Clarivate Analytics - Journal Citation Reports [cited 2020 May 20]. Available from: https://mjl.clarivate.com/home
SCOPUS [cited 2020 May 20]. Available from: https://www.scopus.com/sources
ISSN Portal [cited 2020 May 20]. Available from: https://portal.issn.org/
Stop Predatory Journals - List of Misleading and Fake Metrics [cited 2020 May 20]. Available from: https://predatoryjournals.com/metrics/
Oermann MH, Conklin JL, Nicoll LH, et al. Study of predatory open access nursing journals. J Nurs Scholarsh. 2016;48(6):624-632.
Cobey KD, Lalu MM, Skidmore B, Ahmadzai N, Grudniewicz A, Moher D. What is a predatory journal? A scoping review. F1000Res. 2018;7:1001.
Hansoti B, Langdorf MI, Murphy LS. Discriminating between legitimate and predatory open access journals: Report from the international federation for emergency medicine research committee. West J Emerg Med. 2016;17(5):497-507.
Beall J. Criteria for determining predatory open-access publishers - 3rd edition [cited 2019 Jun 22]. Available from: www.beallslist.weebly.com
R Core Team. A Language and Environment for Statistical Computing. R version 3.6.3 (2020-02-29) ed: R Foundation for Statistical Computing; 2020.
Bulletin of Faculty of Pharmacy, Cairo University [cited 2020 Oct 04]. Available from: https://bfpc.journals.ekb.eg/
Archives of Pharmacy Practice [cited 2020 Oct 01]. Available from: https://archivepp.com/en
Peppard W, Mulvey A, Obenberger S, et al. Defining characteristics of predatory open-access journals in critical care pharmacy practice. Crit Care Med. 2019;47:504.
Selcuk BD. Predatory journals: Who publishes in them and why? J Informetr. 2018;12(4):1296-1311.
Ray Yan J, Baldawi H, Lex J, et al. Predatory publishing in orthopaedic research. J Bone Joint Surg. 2018;100(21):e138.
Bhattacharya S, Kumar R, Vyas S, Singh A, Hossain MM, Marzo RR. A holistic approach to remove the bottlenecks and to improve the quality of medical research in India. J Family Med Prim Care. 2019;8(11):3469-3474.
Misra D, Agarwal V. Open access publishing in india: coverage, relevance, and future perspectives. J Korean Med Sci. 2019;34.
Shamseer L, Moher D, Maduekwe O, et al. Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison. BMC Med. 2017;15(1):28.
Dal-Ré R. Potential predatory journals are colonizing the ICMJE recommendations list of followers. Neth J Med. 2019;77(2):92-96.
Macháček V, Srholec M. Predatory publishing in Scopus: evidence on cross-country differences. Scientometrics. 2021;126(3):1897-1921.
Rupp M, Anastasopoulou L, Wintermeyer E, Malhaan D, El Khassawna T, Heiss C. Predatory journals: a major threat in orthopaedic research. Int Orthop. 2019;43(3):509-517.
O'Kelly F, Fernandez N, Koyle MA. Predatory publishing or a lack of peer review transparency?-a contemporary analysis of indexed open and non-open access articles in paediatric urology. J Pediatr Urol. 2019;15(2):159.e1-159.e7.

Auteurs

Celia Schwertmann (C)

University of Tasmania, Hobart, TAS, Australia.

Colin Curtain (C)

University of Tasmania, Hobart, TAS, Australia.

Gregory Peterson (G)

University of Tasmania, Hobart, TAS, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH